Year |
Citation |
Score |
2019 |
Aird D, Teng T, Huang CL, Pazolli E, Banka D, Cheung-Ong K, Eifert C, Furman C, Wu ZJ, Seiler M, Buonamici S, Fekkes P, Karr C, Palacino J, Park E, et al. Sensitivity to splicing modulation of BCL2 family genes defines cancer therapeutic strategies for splicing modulators. Nature Communications. 10: 137. PMID 30635584 DOI: 10.1038/S41467-018-08150-5 |
0.36 |
|
2019 |
Aird D, Teng T, Huang C, Pazolli E, Banka D, Cheung-Ong K, Eifert C, Furman C, Wu J, Seiler M, Buonamici S, Fekkes P, Karr C, Palacino J, Park E, et al. Abstract 281: Sensitivity to splicing modulation of BCL2 family genes reveals cancer therapeutic strategies for splicing modulators Cancer Research. 79: 281-281. DOI: 10.1158/1538-7445.Sabcs18-281 |
0.375 |
|
2013 |
Hu Z, Chang YC, Wang Y, Huang CL, Liu Y, Tian F, Granger B, Delisi C. VisANT 4.0: Integrative network platform to connect genes, drugs, diseases and therapies. Nucleic Acids Research. 41: W225-31. PMID 23716640 DOI: 10.1093/Nar/Gkt401 |
0.603 |
|
2013 |
Wu-Chou YH, Chen YT, Yeh TH, Chang HC, Weng YH, Lai SC, Huang CL, Chen RS, Huang YZ, Chen CC, Hung J, Chuang WL, Lin WY, Chen CH, Lu CS. Genetic variants of SNCA and LRRK2 genes are associated with sporadic PD susceptibility: a replication study in a Taiwanese cohort. Parkinsonism & Related Disorders. 19: 251-5. PMID 23182315 DOI: 10.1016/j.parkreldis.2012.10.019 |
0.539 |
|
2012 |
Ahn S, Huang CL, Ozkumur E, Zhang X, Chinnala J, Yalcin A, Bandyopadhyay S, Russek S, Unlü MS, DeLisi C, Irani RJ. TATA binding proteins can recognize nontraditional DNA sequences. Biophysical Journal. 103: 1510-7. PMID 23062343 DOI: 10.1016/J.Bpj.2012.08.030 |
0.459 |
|
2012 |
Huang CL, Lamb J, Chindelevitch L, Kostrowicki J, Guinney J, Delisi C, Ziemek D. Correlation set analysis: detecting active regulators in disease populations using prior causal knowledge. Bmc Bioinformatics. 13: 46. PMID 22443377 DOI: 10.1186/1471-2105-13-46 |
0.526 |
|
2012 |
Shigemizu D, Hu Z, Hung JH, Huang CL, Wang Y, DeLisi C. Using functional signatures to identify repositioned drugs for breast, myelogenous leukemia and prostate cancer. Plos Computational Biology. 8: e1002347. PMID 22346740 DOI: 10.1371/Journal.Pcbi.1002347 |
0.553 |
|
2009 |
Hu Z, Hung JH, Wang Y, Chang YC, Huang CL, Huyck M, Delisi C. VisANT 3.5: Multi-scale network visualization, analysis and inference based on the gene ontology Nucleic Acids Research. 37. PMID 19465394 DOI: 10.1093/Nar/Gkp406 |
0.59 |
|
2009 |
Tadigotla V, Alexe G, Sethi N, Bilal E, Huang C, Monti S, Tamayo P, DeLisi C, Bhanot G, Ganesan S. NF-κB Activation in Breast Cancer Occurs Via Different Mechanisms in Triple Negative and HER2+ Tumors with Lymphocytic Infiltrate. Cancer Research. 69: 1164-1164. DOI: 10.1158/0008-5472.Sabcs-09-1164 |
0.495 |
|
Show low-probability matches. |